In July 2015, the House of Representatives passed the 21st Century Cures Act, which contained public science funding and numerous provisions aimed at adjusting how the Food and Drug Administration (FDA) evaluates new medical products and new indications
Read More...
Read the complete post at http://healthaffairs.org/blog/2016/11/30/the-current-21st-century-cures-legislation-is-still-a-bad-deal-for-patients/
Posted
Nov 30 2016, 12:32 PM
by
Health Affairs BlogHealth Affairs Blog